Global Defibrillators Market By Product Type (Advanced Life Support Defibrillators, Automated External Defibrillators, Implantable Cardioverter - Transvenous Implantable Cardioverter Defibrillator, Subcutaneous Implantable Cardioverter Defibrillator; Wearable Defibrillators), End Use (Hospital, Pre-Hospital, Public Access Market, Alternate Care Market, Home Healthcare)
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Global defibrillators market has a potential to reach $ 17,798.5 million by 2022. Defibrillators are devices that are basically used to deliver a therapeutic shock to patients? heart in case of life-threatening medical conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure is used to deliver an electric shock to the heart, depolarizing the heart muscles and restoring the heart to its normal electric impulse. The global defibrillators market is segmented on the basis of product, end-user, and geography. The major product categories of defibrillators are Advanced Life Support (ALS) Defibrillators, Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICD), and Wearable Defibrillators. ICDs are further categorized into transvenous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). The T-ICDs is the most prominent market within the Implantable cardioverter-defibrillator market, and it is due to precision offered and highly targeted functioning.
The report highlights the adoption of Defibrillators globally. Based on the product type; the Defibrillators market is segmented into Advanced Life Support (ALS) Defibrillators, Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICD), Wearable Defibrillators market. Further the Implantable Cardioverter Defibrillators (ICD) segment is sub segmented into Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs) market. Based on the end use avenue, the market is bifurcated into Hospitals, Pre-hospitals, Public Access Markets, Alternate Care Markets, Home Healthcare market. The geographies included in the report are North America, Europe, Asia-Pacific, LAMEA (Latin America, Middle East and Africa).
For the better analysis, the geographies are segmented into countries. The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.